|
2025
|
Invention
|
Crystalline forms of n-(1-(tert-butyl)-1h-pyrazol-4-yl)-2-(4-((6-((methylsulfonyl)quinolin-4-yl)o... |
|
|
Invention
|
N-(1-(tert-butyl)-1 h-pyrazol-4-yl)-2-(4-((6-(quinolin-4-yl)oxy)-phenyl)acet amide derivatives as... |
|
|
Invention
|
Anti-tnfr2 antigen-binding proteins and uses thereof. The present application provides antigen-bi... |
|
|
P/S
|
Chemical or biological ingredients used as a component in pharmaceutical preparations for the tre... |
|
|
P/S
|
Molecules used as a component in pharmaceutical preparations for the treatment of auto-immune dis... |
|
2024
|
Invention
|
Methods of treating a patient with an inflammatory bowel disease. This disclosure relates general... |
|
|
Invention
|
Anti-cdh17 antigen-binding proteins and uses thereof. The present application provides antigen-bi... |
|
|
Invention
|
Cdk2 inhibitors and uses thereof. The present disclosure relates to compounds and pharmaceutical ... |
|
|
Invention
|
Anti-trailr2 antigen-binding proteins and uses thereof. The present application provides antigen-... |
|
|
Invention
|
Inhibitors of ripk2 and uses thereof. The present disclosure relates to RIPK2 inhibitors represen... |
|
|
Invention
|
Modified single-domain antibodies. The present disclosure provides single-domain antibodies compr... |
|
|
Invention
|
Anti-cd25 antigen-binding proteins and uses thereof. The present application provides antigen-bin... |
|
2023
|
Invention
|
Inhibitors of ripk2 and medical uses thereof. The present disclosure relates to RIPK2 inhibitors ... |
|
2022
|
P/S
|
Pharmaceutical products and preparations for the treatment of auto-immune diseases; Molecules use... |
